News Aequus Pharmaceuticals Inc.

Equities

AQS

CA0076361033

Market Closed - Toronto S.E. Other stock markets 09:30:00 2024-04-17 am EDT			5-day change	1st Jan Change
0.015 ^CAD	0.00%		0.00%	-40.00%

2023	Aequus Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Aequus Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aequus Reports Third Quarter 2023 Financial Highlights and General Update	Nov. 29	AQ
Aequus Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 28	CI
Aequus Announces New Financing	23-10-20	AQ
Aequus Announces New Financing and Provides Launch Update of Zimed Preservative Free (Bimatoprost 0.03%)	23-10-06	AQ
Aequus Reports Second Quarter 2023 Financial Highlights and General Update	23-08-29	GL
Aequus Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-28	CI
Aequus Says Zimed PF Now Available in Canada	23-08-24	MT
Aequus Announces Zimed PF Now Available in Canada	23-08-24	GL
Aequus Pharmaceuticals Inc. Announces Launch of Zimed PF in Canada	23-08-24	CI
Aequus Pharmaceuticals Announces Zimed PF Website Launch	23-08-22	MT
Aequus Announces Zimed PF Website Launch	23-08-22	GL
Aequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canada	23-08-21	AQ
Aequus Pharmaceuticals Pauses Sales Of Evolve Intensive Eyedrops, Gel in Canada	23-08-18	MT
Aequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canada	23-08-18	GL
Aequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canada	23-08-18	AQ
Aequus Pharmaceuticals Inc. Announces Pause in Sales of Evolve Intensive Eyedrop and Intensive Gel Products in Canada	23-08-18	CI
Aequus Announces Financing to Support Launch of Zimed Preservative Free	23-07-07	AQ
Aequus Pharmaceuticals Announcds Financing to Support Launch of Zimed Preservative Free	23-07-07	MT
Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%)	23-07-06	GL
Aequus Pharmaceuticals Inc. Increases Its Debt by $400,000 to Support the Launch of Zimed Pf	23-07-05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Aequus Pharmaceuticals Inc.

Equities

AQS

CA0076361033

Summary

Filters